BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36995939)

  • 1. Phosphoantigen sensing combines TCR-dependent recognition of the BTN3A IgV domain and germline interaction with BTN2A1.
    Willcox CR; Salim M; Begley CR; Karunakaran MM; Easton EJ; von Klopotek C; Berwick KA; Herrmann T; Mohammed F; Jeeves M; Willcox BE
    Cell Rep; 2023 Apr; 42(4):112321. PubMed ID: 36995939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Nat Commun; 2023 Nov; 14(1):7617. PubMed ID: 37993425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
    Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
    Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
    Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
    Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.
    Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ
    Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Division of labor and cooperation between different butyrophilin proteins controls phosphoantigen-mediated activation of human γδ T cells.
    Karunakaran MM; Subramanian H; Jin Y; Mohammed F; Kimmel B; Juraske C; Starick L; Nöhren A; Länder N; Willcox CR; Singh R; Schamel WW; Nikolaev VO; Kunzmann V; Wiemer AJ; Willcox BE; Herrmann T
    Res Sq; 2023 Feb; ():. PubMed ID: 36824912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
    Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
    Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations to the BTN2A1 Linker Region Impact Its Homodimerization and Its Cytoplasmic Interaction with Phospho-Antigen-Bound BTN3A1.
    Nguyen K; Jin Y; Howell M; Hsiao CC; Wiemer AJ; Vinogradova O
    J Immunol; 2023 Jul; 211(1):23-33. PubMed ID: 37171180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human γδ T cells by cytosolic interactions of BTN3A1 with soluble phosphoantigens and the cytoskeletal adaptor periplakin.
    Rhodes DA; Chen HC; Price AJ; Keeble AH; Davey MS; James LC; Eberl M; Trowsdale J
    J Immunol; 2015 Mar; 194(5):2390-8. PubMed ID: 25637025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Human γδ T Cells by BTN3A1 Protein Stability and ATP-Binding Cassette Transporters.
    Rhodes DA; Chen HC; Williamson JC; Hill A; Yuan J; Smith S; Rhodes H; Trowsdale J; Lehner PJ; Herrmann T; Eberl M
    Front Immunol; 2018; 9():662. PubMed ID: 29670629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
    Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
    Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR screens decode cancer cell pathways that trigger γδ T cell detection.
    Mamedov MR; Vedova S; Freimer JW; Sahu AD; Ramesh A; Arce MM; Meringa AD; Ota M; Chen PA; Hanspers K; Nguyen VQ; Takeshima KA; Rios AC; Pritchard JK; Kuball J; Sebestyen Z; Adams EJ; Marson A
    Nature; 2023 Sep; 621(7977):188-195. PubMed ID: 37648854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.
    Salim M; Knowles TJ; Baker AT; Davey MS; Jeeves M; Sridhar P; Wilkie J; Willcox CR; Kadri H; Taher TE; Vantourout P; Hayday A; Mehellou Y; Mohammed F; Willcox BE
    ACS Chem Biol; 2017 Oct; 12(10):2631-2643. PubMed ID: 28862425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpaca (
    Fichtner AS; Karunakaran MM; Gu S; Boughter CT; Borowska MT; Starick L; Nöhren A; Göbel TW; Adams EJ; Herrmann T
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6697-6707. PubMed ID: 32139608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
    Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
    J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
    Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
    J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Butyrophilin-Mediated Activation of γδ T Cells from Human Spleen.
    Wang C; Lai AY; Baiu DC; Smith KA; Odorico JS; Wilson K; Schreiber T; de Silva S; Gumperz JE
    J Immunol; 2024 Jan; 212(2):284-294. PubMed ID: 37991420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
    Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
    Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.